Medical Devices

Essure Labeling Information for Patients and Health Care Providers

The original Essure labeling has changed several times since approval in 2002 based on PMA supplements submitted to the FDA and to align with recommendations in the 2016 final guidance, Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization, and with the FDA’s 2018 restriction on the sale and distribution of the device. The current and original labeling is listed below.

Current labeling from Bayer’s website:
Original labeling when Essure was first approved:

 

Page Last Updated: 04/18/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English